Shore Capital Partners announced sale of Florida Autism Center

March 4, 2020 – Shore Capital Partners (“Shore”), a Chicago-based private equity firm focused on microcap investments within the Healthcare and Food and Beverage industries, is pleased to announce the sale of its autism services portfolio company, Florida Autism Center / Fusion Autism Center (“FAC”), to BlueSprig Pediatrics (“BlueSprig”), a leading Houston, Texas based provider of autism services.

Shore Capital partnered with FAC founder Chryssy Moor’s four locations in 2015 with a goal of building the leading autism services platform in the southeast. Led by Chief Executive Officer Kristy Rohwedder, the team at FAC has evolved from its entrepreneurial beginnings into a rapidly growing enterprise, supported by highly scalable corporate infrastructure and a best in class leadership team. FAC is recognized industry wide as a market leader in the southeast with 52 total locations across Florida and Georgia. During the course of the partnership, Shore and the FAC management team have executed a repeatable de novo growth plan that has allowed the Company to scale rapidly in order to bring best-in-class autism services to as many clients as possible.

“We are pleased to have partnered with Kristy and Chryssy to build FAC into one of the leading autism services providers in the country,” said John Hennegan, co-founder of Shore Capital. “FAC demonstrates what is possible when clinically and operationally focused executives and investment professionals collaborate to build a business that provides desperately needed services into an attractive end market.

“Our goal has always been to increase the availability of our valuable services, so we can continue to positively impact the lives of children and families, and our partnership with BlueSprig will only increase our reach. We believe both organizations share an absolute commitment to providing the highest quality clinical services and that our values and philosophies are a wonderful fit,” said Kristy Rohwedder, CEO of FAC. “Shore’s operational oversight and financial support coupled with our management’s industry and clinical expertise helped facilitate the platform’s rapid expansion and we are excited to begin our partnership with BlueSprig to fuel the next phase of growth for FAC.”

The transaction closed on March 4, 2020. Terms of the transaction are not disclosed. Cain Brothers, a division of KeyBanc Capital Markets, provided M&A advisory services and Winston & Strawn provided legal advice to Shore Capital and FAC.